ArticleJournal of clinical medicine2026

Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Şahin Bedir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.